David Archer PhD
- Department of Pediatrics
Associate Professor
- (404) 727-1378
- darcher@emory.edu
-
Aflac Cancer and Blood Disorders Center
2015 Uppergate Drive
Academic Appointment
- Associate Professor of Pediatrics, Emory University
- Assistant Professor, Winship Cancer Institute, Emory University
Education
Degrees
- PhD from University of Liverpool
- BS from University of Dundee
Research
Focus
- My research is focused on the use of stem cell therapy for inherited blood disorders, specifically sickle cell disease. Of particular interest is the pathogenesis of end organ damage, especially in the kidney, and the potential of therapy to prevent or reverse these processes.
Publications
-
Hydroxyurea blunts mitochondrial energy metabolism and osteoblast and osteoclast differentiation exacerbating trabecular bone loss in sickle cell mice.
Cell Death Dis Volume: 15 Page(s): 907
12/18/2024 Authors: Tripathi AK; Dabeer S; Song J; Vikulina T; Roser-Page S; Alvarez JA; Archer DR; Weitzmann MN -
Impact of arginine therapy on kyotorphin in children with sickle cell disease and vaso-occlusive pain.
Blood Adv Volume: 8 Page(s): 3267 - 3271
06/25/2024 Authors: Korman R; Hatabah D; Brown LA; Harris F; Wilkinson H; Rees CA; Bakshi N; Archer DR; Dampier C; Morris CR -
Voxelotor improves red blood cell functionality in children with sickle cell anaemia: An ancillary study of the HOPE-KIDS 1 trial.
EJHaem Volume: 5 Page(s): 125 - 130
02/01/2024 Authors: Chonat S; Fields E; Baratz H; Watt A; Pochron M; Dixon S; Tonda M; Brown C; Archer D -
Accelerated atherosclerosis in beta-thalassemia.
Am J Physiol Heart Circ Physiol Volume: 325 Page(s): H1133 - H1143
11/01/2023 Authors: Hurtado J; Sellak H; Joseph G; Lewis CV; Naudin CR; Garcia S; Wodicka JR; Archer DR; Taylor WR -
Intestinal barrier dysfunction in murine sickle cell disease is associated with small intestine neutrophilic inflammation, oxidative stress, and dysbiosis.
FASEB Bioadv Volume: 5 Page(s): 199 - 210
05/01/2023 Authors: Lewis CV; Sellak H; Sawan MA; Joseph G; Darby TM; VanInsberghe D; Naudin CR; Archer DR; Jones RM; Taylor WR -
DEVELOPMENT OF A HUMANIZED MOUSE MODEL OF CHOLESTATIC SICKLE CELL DISEASE
Volume: 76 Page(s): S1025 - S1026
10/01/2022 Authors: Michael A; Dawson PA; Karpen SJ; Archer DR -
Increasing nitric oxide bioavailability fails to improve collateral vessel formation in humanized sickle cell mice.
Lab Invest Volume: 102 Page(s): 805 - 813
08/01/2022 Authors: Lewis CV; Sellak H; Hansen L; Joseph G; Hurtado J; Archer DR; Jun H-W; Brown LA; Taylor WR -
Sickle Cell Transplantation Evaluation of Long-term and Late Effects Registry (STELLAR) to Compare Long-term Outcomes After Hematopoietic Cell Transplantation to Those in Siblings Without Sickle Cell Disease and in Nontransplanted Individuals With Sickle Cell Disease: Design and Feasibility Study.
JMIR Res Protoc Volume: 11 Page(s): e36780
07/06/2022 Authors: Krishnamurti L; Arnold SD; Haight A; Abraham A; Guilcher GM; John T; Bakshi N; Shenoy S; Syrjala K; Martin PL -
Adhesion molecules and cerebral microvascular hemodynamic abnormalities in sickle cell disease.
Front Neurol Volume: 13 Page(s): 976063
01/01/2022 Authors: Abi Rached NM; Gbotosho OT; Archer DR; Jones JA; Sterling MS; Hyacinth HI -
CHRONIC INFLAMMATION PROMOTES HEPATIC FIBROSIS IN A HUMANIZED MICE MODEL OF SICKLE CELL DISEASE
Volume: 74 Page(s): 807A - 807A
10/01/2021 Authors: Michael AOA; Flowers-Steele J; Song H; Platt MO; Archer DR